Suppression of dual-specificity phosphatase–2 by hypoxia increases chemoresistance and malignancy in human cancer cells

Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells

(2010) D Mahalingam et al.   BRITISH JOURNAL OF CANCER

Targeted Knockdown of EGR-1 Inhibits IL-8 Production and IL-8-mediated Invasion of Prostate Cancer Cells through Suppressing EGR-1/NF-κB Synergy

(2009) Jiajia Ma et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Epidermal-growth-factor-induced proliferation of astrocytes requires Egr transcription factors

(2009) S. I. Mayer et al.   JOURNAL OF CELL SCIENCE

Downregulation of CD36 results in reduced phagocytic ability of peritoneal macrophages of women with endometriosis

(2009) Pei-Chin Chuang et al.   JOURNAL OF PATHOLOGY

Osteopontin is involved in the development of acquired chemo-resistance of cisplatin in small cell lung cancer

(2009) Tao Gu et al.   LUNG CANCER

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

(2009) G L Semenza   ONCOGENE

Regulation of CD151 by Hypoxia Controls Cell Adhesion and Metastasis in Colorectal Cancer

(2008) C.-W. Chien et al.   CLINICAL CANCER RESEARCH

Involvement of Hypoxia-inducing Factor-1α-dependent Plasminogen Activator Inhibitor-1 Up-regulation in Cyr61/CCN1-induced Gastric Cancer Cell Invasion

(2008) Ming-Tsan Lin et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Spatiotemporal Regulation of ERK2 by Dual Specificity Phosphatases

(2008) Christopher J. Caunt et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Induction of Pyruvate Dehydrogenase Kinase-3 by Hypoxia-inducible Factor-1 Promotes Metabolic Switch and Drug Resistance

(2008) Chun-Wun Lu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY